258 related articles for article (PubMed ID: 14739238)
1. Crystal structure of the catalytic fragment of murine poly(ADP-ribose) polymerase-2.
Oliver AW; Amé JC; Roe SM; Good V; de Murcia G; Pearl LH
Nucleic Acids Res; 2004; 32(2):456-64. PubMed ID: 14739238
[TBL] [Abstract][Full Text] [Related]
2. Crystal structure of the catalytic domain of human PARP2 in complex with PARP inhibitor ABT-888.
Karlberg T; Hammarström M; Schütz P; Svensson L; Schüler H
Biochemistry; 2010 Feb; 49(6):1056-8. PubMed ID: 20092359
[TBL] [Abstract][Full Text] [Related]
3. Poly(ADP-ribose) polymerase-1 activation during DNA damage and repair.
Dantzer F; Amé JC; Schreiber V; Nakamura J; Ménissier-de Murcia J; de Murcia G
Methods Enzymol; 2006; 409():493-510. PubMed ID: 16793420
[TBL] [Abstract][Full Text] [Related]
4. Structural basis for inhibitor specificity in human poly(ADP-ribose) polymerase-3.
Lehtiö L; Jemth AS; Collins R; Loseva O; Johansson A; Markova N; Hammarström M; Flores A; Holmberg-Schiavone L; Weigelt J; Helleday T; Schüler H; Karlberg T
J Med Chem; 2009 May; 52(9):3108-11. PubMed ID: 19354255
[TBL] [Abstract][Full Text] [Related]
5. Characterization of sPARP-1. An alternative product of PARP-1 gene with poly(ADP-ribose) polymerase activity independent of DNA strand breaks.
Sallmann FR; Vodenicharov MD; Wang ZQ; Poirier GG
J Biol Chem; 2000 May; 275(20):15504-11. PubMed ID: 10809783
[TBL] [Abstract][Full Text] [Related]
6. The 193-kD vault protein, VPARP, is a novel poly(ADP-ribose) polymerase.
Kickhoefer VA; Siva AC; Kedersha NL; Inman EM; Ruland C; Streuli M; Rome LH
J Cell Biol; 1999 Sep; 146(5):917-28. PubMed ID: 10477748
[TBL] [Abstract][Full Text] [Related]
7. Structure of the catalytic fragment of poly(AD-ribose) polymerase from chicken.
Ruf A; Mennissier de Murcia J; de Murcia G; Schulz GE
Proc Natl Acad Sci U S A; 1996 Jul; 93(15):7481-5. PubMed ID: 8755499
[TBL] [Abstract][Full Text] [Related]
8. The mechanism of the elongation and branching reaction of poly(ADP-ribose) polymerase as derived from crystal structures and mutagenesis.
Ruf A; Rolli V; de Murcia G; Schulz GE
J Mol Biol; 1998 Apr; 278(1):57-65. PubMed ID: 9571033
[TBL] [Abstract][Full Text] [Related]
9. Binding mode of novel 1-substituted quinazoline derivatives to poly(ADP-ribose) polymerase-catalytic domain, revealed by X-ray crystal structure analysis of complexes.
Matsumoto K; Kondo K; Ota T; Kawashima A; Kitamura K; Ishida T
Biochim Biophys Acta; 2006 May; 1764(5):913-9. PubMed ID: 16631419
[TBL] [Abstract][Full Text] [Related]
10. Novel inhibitors of poly(ADP-ribose) polymerase/PARP1 and PARP2 identified using a cell-based screen in yeast.
Perkins E; Sun D; Nguyen A; Tulac S; Francesco M; Tavana H; Nguyen H; Tugendreich S; Barthmaier P; Couto J; Yeh E; Thode S; Jarnagin K; Jain A; Morgans D; Melese T
Cancer Res; 2001 May; 61(10):4175-83. PubMed ID: 11358842
[TBL] [Abstract][Full Text] [Related]
11. Poly(ADP-ribose) polymerase inhibitors.
Southan GJ; Szabó C
Curr Med Chem; 2003 Feb; 10(4):321-40. PubMed ID: 12570705
[TBL] [Abstract][Full Text] [Related]
12. Crystallization and X-ray crystallographic analysis of recombinant chicken poly(ADP-ribose) polymerase catalytic domain produced in Sf9 insect cells.
Jung S; Miranda EA; de Murcia JM; Niedergang C; Delarue M; Schulz GE; de Murcia GM
J Mol Biol; 1994 Nov; 244(1):114-6. PubMed ID: 7966315
[TBL] [Abstract][Full Text] [Related]
13. Inhibitor and NAD+ binding to poly(ADP-ribose) polymerase as derived from crystal structures and homology modeling.
Ruf A; de Murcia G; Schulz GE
Biochemistry; 1998 Mar; 37(11):3893-900. PubMed ID: 9521710
[TBL] [Abstract][Full Text] [Related]
14. The 40 kDa carboxy-terminal domain of poly(ADP-ribose) polymerase-1 forms catalytically competent homo- and heterodimers in the absence of DNA.
Mendoza-Alvarez H; Alvarez-Gonzalez R
J Mol Biol; 2004 Feb; 336(1):105-14. PubMed ID: 14741207
[TBL] [Abstract][Full Text] [Related]
15. Multiple receptor conformation docking, dock pose clustering and 3D QSAR studies on human poly(ADP-ribose) polymerase-1 (PARP-1) inhibitors.
Fatima S; Jatavath MB; Bathini R; Sivan SK; Manga V
J Recept Signal Transduct Res; 2014 Oct; 34(5):417-30. PubMed ID: 25046176
[TBL] [Abstract][Full Text] [Related]
16. Toward specific functions of poly(ADP-ribose) polymerase-2.
Yélamos J; Schreiber V; Dantzer F
Trends Mol Med; 2008 Apr; 14(4):169-78. PubMed ID: 18353725
[TBL] [Abstract][Full Text] [Related]
17. Functional interactions of p53 with poly(ADP-ribose) polymerase (PARP) during apoptosis following DNA damage: covalent poly(ADP-ribosyl)ation of p53 by exogenous PARP and noncovalent binding of p53 to the M(r) 85,000 proteolytic fragment.
Kumari SR; Mendoza-Alvarez H; Alvarez-Gonzalez R
Cancer Res; 1998 Nov; 58(22):5075-8. PubMed ID: 9823314
[TBL] [Abstract][Full Text] [Related]
18. Inhibitor-induced structural change of the active site of human poly(ADP-ribose) polymerase.
Kinoshita T; Nakanishi I; Warizaya M; Iwashita A; Kido Y; Hattori K; Fujii T
FEBS Lett; 2004 Jan; 556(1-3):43-6. PubMed ID: 14706823
[TBL] [Abstract][Full Text] [Related]
19. Identification of novel PARP-1 inhibitors by structure-based virtual screening.
Hannigan K; Kulkarni SS; Bdzhola VG; Golub AG; Yarmoluk SM; Talele TT
Bioorg Med Chem Lett; 2013 Nov; 23(21):5790-4. PubMed ID: 24074844
[TBL] [Abstract][Full Text] [Related]
20. Double-stranded DNA binding domain of poly(ADP-ribose) polymerase-1 and molecular insight into the regulation of its activity.
Huambachano O; Herrera F; Rancourt A; Satoh MS
J Biol Chem; 2011 Mar; 286(9):7149-60. PubMed ID: 21183686
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
